Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Stock Up 21.6 %

STRM stock opened at $2.70 on Friday. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The firm has a 50 day simple moving average of $3.81 and a 200-day simple moving average of $5.59. The company has a market capitalization of $11.39 million, a P/E ratio of -0.49 and a beta of 1.64. Streamline Health Solutions has a twelve month low of $1.85 and a twelve month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The company had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.